AU Patent

AU2017222964B2 — Glycosidase inhibitors

Assigned to Asceneuron SA · Expires 2020-01-02 · 6y expired

What this patent protects

Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

USPTO Abstract

Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

Drugs covered by this patent

Patent Metadata

Patent number
AU2017222964B2
Jurisdiction
AU
Classification
—
Expires
2020-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Asceneuron SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.